Brief: Vista Pharma Approves Change Of Designation Of Dhananjaya Alli To Managing Director
10/05/2018 13:11
May 10 (Reuters) - Vista Pharmaceuticals Ltd VIPH.BO :
* VISTA PHARMACEUTICALS - APPROVES CHANGE OF DESIGNATION OF
DHANANJAYA ALLI, CHAIRMAN CUM MANAGING DIRECTOR TO MANAGING
DIRECTOR
Source text for Eikon: ID:nBSE2ww60D
Further company coverage: VIPH.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vista Pharmaceuticals
See all newsBrief: Vista Pharmaceuticals Enters Joint Venture With Pleiades Therapeutics
Brief: Vista Pharmaceuticals To Issue 48.9 Million Warrants At 12 Rupees Each
Brief: Vista Pharmaceuticals To Issue Upto 17.4 Million Shares At Rupees 12.96 Each On Preferential Basis
Brief: Vista Pharmaceuticals To Consider Proposal For Raising Funds By Way Of Issue Of Preferential Issue Of Shares
Brief: Vista Pharmaceuticals Names Dhananjaya Alli As Chairman